Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) saw a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 960,700 shares, a drop of 29.9% from the January 15th total of 1,370,000 shares. Based on an average daily trading volume, of 1,840,000 shares, the days-to-cover […]
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) saw a significant decline in short interest in the month of September. As of September 15th, there was short interest totalling 227,100 shares, a decline of 14.9% from the August 31st total of 267,000 shares. Currently, 1.1% of the company’s shares are sold short. Based on an […]
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) was the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 286,200 shares, an increase of 79.0% from the July 31st total of 159,900 shares. Currently, 1.4% of the shares of the stock are sold short. Based […]
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) saw a large growth in short interest during the month of August. As of August 15th, there was short interest totalling 286,200 shares, a growth of 79.0% from the July 31st total of 159,900 shares. Currently, 1.4% of the shares of the stock are short sold. Based […]
Chardan Capital restated their buy rating on shares of Better Therapeutics (NASDAQ:BTTX – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $9.00 target price on the stock. Separately, Lake Street Capital lowered their price objective on shares of Better Therapeutics from $6.00 to $5.00 and set a buy […]